Rapid advances in multimodality therapy have not significantly improved the overall 5-yr survival of oral cancer patients in the past two decades, thereby underscoring the need for molecular therapeutics. The development of new treatment strategies for more effective management of oral cancer requir
Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis
β Scribed by Dritan Turhani; Kurt Krapfenbauer; Dietmar Thurnher; Hanno Langen; Michael Fountoulakis
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 193 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0173-0835
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Head and neck squamous cell carcinoma (HNSCC) affects nearly 500,000 individuals worldwide each year, with nearly 40,000 patients in the US alone. The 5-year survival rate is approximately 50%, and has not improved significantly in the past 20 years despite extensive efforts to increase cure rates.
## Abstract Cyclin D1 is a wellβknown cell cycle regulator. Recently, its proβsurvival function has been revealed in several tumors. Because increasing expression of cyclin D1 is a common event in oral squamous cell carcinoma (OSCC) and has been correlated with cisplatin resistance, we investigated
Therapy with IL-12 or IL-2 induces tumor regression in only a few patients with head-and-neck squamous cell carcinoma (SCC), and the factors promoting responsiveness have not been well defined. In this study, we examined whether combined IL-12 and IL-2 therapy can induce tumor regression in a new mu
## Abstract The proteomic profiles of a human hepatoma revertant, CL1, and its original cell line, SMMC7721, were compared by using an improved twoβdimensional electrophoresis (2βDE) procedure, with multiβIPGstrips gels (length β€ 13Β cm) run simultaneously on one sodium dodecyl sulfate (SDS) gel (sh